Doximity (NASDAQ:DOCS) Price Target Lowered to $60.00 at JPMorgan Chase & Co.
Doximity (NASDAQ:DOCS – Free Report) had its target price trimmed by JPMorgan Chase & Co. from $63.00 to $60.00 in a research report report published on Tuesday morning,Benzinga reports. The firm currently has a neutral rating on the stock. Other analysts also recently issued reports about the company. Mizuho cut their target price on Doximity […]
More Stories
Mercury Systems Inc $MRCY Shares Sold by Invesco Ltd.
Invesco Ltd. decreased its stake in Mercury Systems Inc (NASDAQ:MRCY – Free Report) by 3.4% in the 1st quarter, according...
Townsquare Capital LLC Invests $254,000 in Renasant Co. $RNST
Townsquare Capital LLC acquired a new position in Renasant Co. (NASDAQ:RNST – Free Report) during the 1st quarter, HoldingsChannel.com reports....
Connor Clark & Lunn Investment Management Ltd. Buys Shares of 2,968 Choice Hotels International, Inc. $CHH
Connor Clark & Lunn Investment Management Ltd. purchased a new position in Choice Hotels International, Inc. (NYSE:CHH – Free Report)...
Invesco Ltd. Has $29.09 Million Position in Catalyst Pharmaceuticals, Inc. $CPRX
Invesco Ltd. raised its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 41.7% during the 1st quarter, according...
Swiss National Bank Has $4.17 Million Stock Position in Teradata Corporation $TDC
Swiss National Bank trimmed its stake in Teradata Corporation (NYSE:TDC – Free Report) by 1.9% during the 1st quarter, according...
Invesco Ltd. Buys 66,942 Shares of Ichor Holdings, Ltd. $ICHR
Invesco Ltd. boosted its stake in Ichor Holdings, Ltd. (NASDAQ:ICHR – Free Report) by 6.1% in the first quarter, according...